Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1999 Feb;58(2):103–108. doi: 10.1136/ard.58.2.103

Optimised sample preparation of synovial fluid for detection of Chlamydia trachomatis DNA by polymerase chain reaction

J Kuipers 1, L Nietfeld 1, U Dreses-Werringloe 1, L Koehler 1, J Wollenhaupt 1, H Zeidler 1, M Hammer 1
PMCID: PMC1752829  PMID: 10343525

Abstract

OBJECTIVE—To optimise sample preparation of synovial fluid for Chlamydia trachomatis (CT) specific polymerase chain reaction (PCR).
METHODS—Serial dilutions of purified CT elementary bodies in synovial fluid were prepared. The synovial fluid pellet was processed by eight different methods of sample preparation. Then samples were analysed by CT specific PCR. The sensitivity of PCR was the basis of ranking of the eight different methods.
RESULTS—Highest sensitivity was achieved by methods including an additional step of DNA isolation. Additional extraction of protein and polysaccharides by cetyltrimethylammonium bromide (CTAB) increased sensitivity. Addition of hyaluronidase did not increase sensitivity of QIAEX-DNA extraction but was necessary, however, before phenol-chloroform-DNA extraction.
CONCLUSIONS—The method of synovial fluid sample preparation significantly influences the sensitivity of subsequent PCR. Additional DNA isolation and extraction of PCR inhibitors by CTAB led to higher sensitivity.

 Keywords: Chlamydia trachomatis; polymerase chain reaction; synovial fluid

Full Text

The Full Text of this article is available as a PDF (121.9 KB).

Figure 1  .

Figure 1  

The eight different methods for processing of synovial fluid analysed in this study.

Figure 2  .

Figure 2  

Number of fluorescent particles (depicted on the y axis) per inclusion forming unit (IFU, shown on the x axis). Dilutions of three randomly selected aliquots from the stock of purified C trachomatis were analysed by immunofluorescence. Three slides per dilution per aliquot were analysed. The calculated curve for linear regression is shown (slope = 7.7, r2 = 0.82, p<0.0001).

Figure 3  .

Figure 3  

Electrophoresis of amplified DNA by nested PCR for serial 10-fold dilutions of persistently infected PBMo in synovial fluid. Lanes 1 and 9: molecular weight marker (pBR322 cleaved with HaeIII), lane 2: positive control (purified DNA of C trachomatis), lanes 3 and 8: negative controls prepared together with the other samples (lane 3: distilled water, lane 8: synovial fluid from RA patient), lanes 4, 5, 6, and 7: 10-fold serial dilutions of persistently infected PBMo from 102 to 10-1 PBMo per ml of synovial fluid. Left panel: dilution series processed by method (3b). Right panel: dilution series processed by method (4b).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bas S., Griffais R., Kvien T. K., Glennås A., Melby K., Vischer T. L. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum. 1995 Jul;38(7):1005–1013. doi: 10.1002/art.1780380718. [DOI] [PubMed] [Google Scholar]
  2. Hammer M., Nettelnbreker E., Hopf S., Schmitz E., Pörschke K., Zeidler H. Chlamydial rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis. Clin Exp Rheumatol. 1992 Jan-Feb;10(1):63–66. [PubMed] [Google Scholar]
  3. Koehler L., Nettelnbreker E., Hudson A. P., Ott N., Gérard H. C., Branigan P. J., Schumacher H. R., Drommer W., Zeidler H. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog. 1997 Mar;22(3):133–142. doi: 10.1006/mpat.1996.0103. [DOI] [PubMed] [Google Scholar]
  4. Kuipers J. G., Scharmann K., Wollenhaupt J., Nettelnbreker E., Hopf S., Zeidler H. Sensitivities of PCR, MicroTrak, ChlamydiaEIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid. J Clin Microbiol. 1995 Dec;33(12):3186–3190. doi: 10.1128/jcm.33.12.3186-3190.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Liebling M. R., Nishio M. J., Rodriguez A., Sigal L. H., Jin T., Louie J. S. The polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids. Arthritis Rheum. 1993 May;36(5):665–675. doi: 10.1002/art.1780360514. [DOI] [PubMed] [Google Scholar]
  6. Maass M., Dalhoff K. Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR. J Clin Microbiol. 1994 Oct;32(10):2616–2619. doi: 10.1128/jcm.32.10.2616-2619.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nanagara R., Li F., Beutler A., Hudson A., Schumacher H. R., Jr Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum. 1995 Oct;38(10):1410–1417. doi: 10.1002/art.1780381008. [DOI] [PubMed] [Google Scholar]
  8. Poole E. S., Highton J., Wilkins R. J., Lamont I. L. A search for Chlamydia trachomatis in synovial fluids from patients with reactive arthritis using the polymerase chain reaction and antigen detection methods. Br J Rheumatol. 1992 Jan;31(1):31–34. doi: 10.1093/rheumatology/31.1.31. [DOI] [PubMed] [Google Scholar]
  9. Schachter J. Chlamydial infections. West J Med. 1990 Nov;153(5):523–534. [PMC free article] [PubMed] [Google Scholar]
  10. Schmitz E., Nettelnbreker E., Zeidler H., Hammer M., Manor E., Wollenhaupt J. Intracellular persistence of chlamydial major outer-membrane protein, lipopolysaccharide and ribosomal RNA after non-productive infection of human monocytes with Chlamydia trachomatis serovar K. J Med Microbiol. 1993 Apr;38(4):278–285. doi: 10.1099/00222615-38-4-278. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES